1. Referans1. London WT, Petrick JL, KA. M. Liver cancer. In: Thun MJ LM, Cerhan JR, Haiman CA, Schottenfeld D, editor. In Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018. p. 635-60.
2. Referans2. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364-78.
3. Referans3. Ju SM, Kang JG, Bae JS, Pae HO, Lyu YS, Jeon BH. The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial Cells. Evid Based Complement Alternat Med. 2015;2015:186436.
4. Referans4. Lavery HJ, Cooperberg MR. Clinically localized prostate cancer in 2017: A review of comparative effectiveness. Urol Oncol. 2017;35:40-1.
5. Referans5. Vijayan P, Raghu C, Ashok G, Dhanaraj SA, Suresh B. Antiviral activity of medicinal plants of Nilgiris. Indian J Med Res. 2004;120:24-9.